12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement in Monday's intraday session. Redhill Biopharma (RDHL) led the gainers with a 207.0% increase, while Harpoon Therapeutics (HARP) led the losers with a 25.1% decrease. Other notable movers included Biodexa Pharmaceuticals (BDRX), Tharimmune (THAR), Lexaria Bioscience (LEXX), and Mira Pharmaceuticals (MIRA) on the gainers' side, and Telesis Bio (TBIO), Altamira Therapeutics (CYTO), Universe Pharmaceuticals (UPC), Kazia Therapeutics (KZIA), and UpHealth (UPH) among the losers.
November 27, 2023 | 5:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biodexa Pharmaceuticals' stock increased by 119.89% to $6.13, with a market cap of $4.2 million.
The dramatic rise in Biodexa Pharmaceuticals' stock price could be driven by positive news or developments, but the small market cap indicates potential for high volatility.
CONFIDENCE 75
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Lexaria Bioscience's stock rose 24.42% to $1.63, with a market cap of $15.8 million.
The significant increase in Lexaria Bioscience's stock price could reflect investor confidence, but the relatively small market cap means the stock may remain volatile.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Mira Pharmaceuticals' stock increased by 21.06% to $3.96, with a market cap of $58.5 million.
Mira Pharmaceuticals' stock price increase suggests favorable investor sentiment, and the larger market cap compared to others mentioned may offer more stability.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Redhill Biopharma's stock soared 207.0% to $0.97, with a market cap of $10.7 million.
A 207% increase in stock price is a significant event that suggests a very positive development for the company, likely to attract investor interest and potentially sustain short-term momentum.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Tharimmune's shares increased by 27.3% to $3.66, with a market cap of $2.5 million.
Tharimmune's stock price rise indicates positive sentiment, but the small market cap suggests that the stock could be subject to significant price swings.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Harpoon Therapeutics' shares fell by 25.1% to $8.96, with a market cap of $151.6 million.
A 25.1% drop is a substantial negative movement, indicating a strong bearish sentiment or negative news that could continue to pressure the stock in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100